Maxposure Limited — Others, 28-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Maxposure Limited has announced a board meeting on the financial results for the quarter and half-year. The company confirmed no deviation in the use of IPO funds totaling ₹20.26 Cr after shareholders approved reallocating proceeds to include a strategic acquisition and investment in the aviation sector. This move aims to widen market presence and diversify offerings, enhancing growth and competitiveness. ₹5.07 Cr of the IPO proceeds have been redirected to support this acquisition, underscoring a focus on long-term value creation for shareholders.